Personalized medicine and pathology: friend or foe?
作者信息
Aspinall Mara
机构信息
Genzyme Corporation, Cambridge, MA 02142, USA.
出版信息
Arch Pathol Lab Med. 2009 Apr;133(4):527-8. doi: 10.5858/133.4.527.
PMID:19391644
Abstract
摘要
相似文献
1
Personalized medicine and pathology: friend or foe?
Arch Pathol Lab Med. 2009 Apr;133(4):527-8. doi: 10.5858/133.4.527.
2
Next-Generation Pathology.
Methods Mol Biol. 2016;1386:61-72. doi: 10.1007/978-1-4939-3283-2_4.
3
[Impact of the pathology in modern medicine].
Med Sci (Paris). 2011 Jun-Jul;27(6-7):651-5. doi: 10.1051/medsci/2011276018. Epub 2011 Jul 1.
4
Morphogenomics and morphoproteomics: a role for anatomic pathology in personalized medicine.
Arch Pathol Lab Med. 2009 Apr;133(4):568-79. doi: 10.5858/133.4.568.
5
Preparing pathology for precision medicine: challenges and opportunities.
Virchows Arch. 2017 Aug;471(2):141-146. doi: 10.1007/s00428-017-2141-z. Epub 2017 May 16.
6
The role of pathologists in the era of personalized medicine.
Arch Pathol Lab Med. 2009 Apr;133(4):605-10. doi: 10.5858/133.4.605.
7
[Medicine in the land of stones].
Pathologe. 2003 May;24(3):236-7. doi: 10.1007/s00292-003-0615-z. Epub 2003 Mar 21.
8
Physicians in "the war against medicine".
Conn Med. 2003 Apr;67(4):250.
9
Pathology and laboratory medicine.
JAMA. 1992 Jul 15;268(3):397-9.
10
Reflections about evidence-based pathology.
Int J Surg Pathol. 2007 Jul;15(3):230-2. doi: 10.1177/1066896907303207.
Zotero 插件